Citation Impact

Citing Papers

Should pharmacogenetics be incorporated in major depression treatment? Economic evaluation in high- and middle-income European countries
2011
Cognition and Depression: Current Status and Future Directions
2010 Standout
Depression
2018 Standout
Major depressive disorder
2016 Standout
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
Herbal medicine for depression, anxiety and insomnia: A review of psychopharmacology and clinical evidence
2011 Standout
The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis
2007
Depressive disorders—is it time to endorse different pathophysiologies?
2005
When brain clocks lose track of time: cause or consequence of neuropsychiatric disorders
2011 StandoutNobel
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
2006
The pharmacology of putative early-onset antidepressant strategies
2003
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Circadian rhythms and sleep in bipolar disorder
2010
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters
2005 StandoutNature
Beyond diathesis stress: Differential susceptibility to environmental influences.
2009 Standout
A Transdiagnostic Approach to Treating Sleep Disturbance in Psychiatric Disorders
2009
Pharmacogenetics of Antidepressants
2011
Depression in adolescence
2012 Standout
Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response
2004
A Susceptibility Gene for Affective Disorders and the Response of the Human Amygdala
2005
Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test
2005
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
2014 Standout
Serotonin and decision making processes
2011
Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders
2002
Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies
2011 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Sleep and Circadian Rhythms in Bipolar Disorder: Seeking Synchrony, Harmony, and Regulation
2008
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
2015
Emotion and Decision Making
2014 Standout
Duloxetine versus other anti-depressive agents for depression
2012
Industry sponsorship and research outcome
2017 Standout

Works of Danilo Dotoli being referenced

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-httlpr in delusional and nondelusional depression
2001
Relapse during a 6-month continuation treatment with fluvoxamine in an Italian population: The role of clinical, psychosocial and genetic variables
2006
Further evidence of a combined effect of SERTPR and TPH on SSRIs response in mood disorders
2004
Dark therapy for mania: a pilot study
2005
Pharmacogenetics of selective serotonin reuptake inhibitor response
2004
Rankless by CCL
2026